Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shorter vs Standard Steroid Therapy in Nephrotic Syndrome
NCT03878914Phase 4Terminated
- Sponsor
- Wayne State University
- Start
- Aug 2019
- Primary completion
- Oct 2021
- Countries
- 2
01
Overview
Phase 4, open-label trial of corticosteroids in Idiopathic nephrotic syndrome (INS) (2 arms), sponsored by Wayne State University. Primary endpoint: Time to first relapse. Started Aug 2019; status: terminated.
02
Drugs
corticosteroids
03
Conditions
Idiopathic nephrotic syndrome (INS)
Beyond the preview
Go deeper on NCT03878914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03878914.